Lesley Castillo

1.5k total citations
18 papers, 948 citations indexed

About

Lesley Castillo is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Lesley Castillo has authored 18 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Lesley Castillo's work include Prostate Cancer Treatment and Research (7 papers), Regulation of Appetite and Obesity (3 papers) and Adipose Tissue and Metabolism (3 papers). Lesley Castillo is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Regulation of Appetite and Obesity (3 papers) and Adipose Tissue and Metabolism (3 papers). Lesley Castillo collaborates with scholars based in Australia, Germany and United States. Lesley Castillo's co-authors include Lisa G. Horvath, Ronaldo F. Enriquez, Amanda Sainsbury, Paul A. Baldock, Shu Lin, Herbert Herzog, Roger J. Daly, Yan‐Chuan Shi, Hui‐Ming Lin and Hui Zhang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cell Metabolism.

In The Last Decade

Lesley Castillo

18 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lesley Castillo Australia 14 402 242 232 208 185 18 948
Vittoria Carnicelli Italy 17 457 1.1× 113 0.5× 103 0.4× 224 1.1× 87 0.5× 47 1000
Fabin Dang China 10 457 1.1× 116 0.5× 199 0.9× 243 1.2× 114 0.6× 12 906
Jan Kroon Netherlands 20 455 1.1× 136 0.6× 86 0.4× 288 1.4× 194 1.0× 42 1.2k
Katja Kaipio Finland 16 358 0.9× 161 0.7× 96 0.4× 244 1.2× 57 0.3× 29 797
Valérie Gratio France 17 367 0.9× 244 1.0× 159 0.7× 217 1.0× 102 0.6× 25 1.1k
Connie Wang United States 8 437 1.1× 232 1.0× 134 0.6× 157 0.8× 44 0.2× 13 896
Xueran Chen China 19 729 1.8× 320 1.3× 80 0.3× 162 0.8× 114 0.6× 45 1.1k
Raymond Rothstein United States 15 391 1.0× 102 0.4× 71 0.3× 311 1.5× 221 1.2× 19 1.5k
Sandra Meulemans Belgium 19 470 1.2× 110 0.5× 128 0.6× 119 0.6× 51 0.3× 29 1.0k

Countries citing papers authored by Lesley Castillo

Since Specialization
Citations

This map shows the geographic impact of Lesley Castillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley Castillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley Castillo more than expected).

Fields of papers citing papers by Lesley Castillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lesley Castillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley Castillo. The network helps show where Lesley Castillo may publish in the future.

Co-authorship network of co-authors of Lesley Castillo

This figure shows the co-authorship network connecting the top 25 collaborators of Lesley Castillo. A scholar is included among the top collaborators of Lesley Castillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley Castillo. Lesley Castillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Law, Andrew M. K., Etienne Masle‐Farquhar, Lesley Castillo, et al.. (2022). Activation of the viral sensor oligoadenylate synthetase 2 (Oas2) prevents pregnancy-driven mammary cancer metastases. Breast Cancer Research. 24(1). 31–31. 8 indexed citations
2.
Castillo, Lesley, Adelaide I.J. Young, Amanda Mawson, et al.. (2019). MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma. Oncogene. 39(8). 1821–1829. 16 indexed citations
3.
Lin, Hui‐Ming, Iva Nikolić, Jessica Yang, et al.. (2018). MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer. Scientific Reports. 8(1). 7820–7820. 39 indexed citations
4.
Lin, Hui‐Ming, Brian Y. Lee, Lesley Castillo, et al.. (2018). Effect of FAK inhibitor VS‐6063 (defactinib) on docetaxel efficacy in prostate cancer. The Prostate. 78(4). 308–317. 51 indexed citations
5.
Law, Andrew M. K., Julia Yin, Lesley Castillo, et al.. (2017). Andy’s Algorithms: new automated digital image analysis pipelines for FIJI. Scientific Reports. 7(1). 15717–15717. 37 indexed citations
6.
Young, Adelaide I.J., Andrew M. K. Law, Lesley Castillo, et al.. (2016). MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib. Breast Cancer Research. 18(1). 125–125. 64 indexed citations
7.
Mahon, Kate, Lesley Castillo, Mark D. Chatfield, et al.. (2015). Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer. British Journal of Cancer. 112(8). 1340–1348. 45 indexed citations
8.
Mahon, Kate, Wenjia Qu, James Devaney, et al.. (2014). Methylated glutathione s-transferase 1 (mGSTP1) as a potential plasma epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 32(4_suppl). 11–11. 5 indexed citations
9.
Lin, Hui‐Ming, Lesley Castillo, Kate Mahon, et al.. (2014). Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer. British Journal of Cancer. 110(10). 2462–2471. 120 indexed citations
10.
Mahon, Kate, James Devaney, Cheryl Paul, et al.. (2014). Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer. British Journal of Cancer. 111(9). 1802–1809. 68 indexed citations
11.
Lee, Brian Y., Falko Hochgräfe, Hui‐Ming Lin, et al.. (2013). Phosphoproteomic Profiling Identifies Focal Adhesion Kinase as a Mediator of Docetaxel Resistance in Castrate-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 13(1). 190–201. 41 indexed citations
12.
Shi, Yan‐Chuan, Jackie Lau, Lin Zhou, et al.. (2013). Arcuate NPY Controls Sympathetic Output and BAT Function via a Relay of Tyrosine Hydroxylase Neurons in the PVN. Cell Metabolism. 18(1). 144–144. 3 indexed citations
13.
Horvath, Lisa G., Mark D. Chatfield, Hui‐Ming Lin, et al.. (2013). The role of macrophages in docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 31(15_suppl). e22175–e22175. 1 indexed citations
14.
Shi, Yan‐Chuan, Jackie Lau, Hui Zhang, et al.. (2013). Arcuate NPY Controls Sympathetic Output and BAT Function via a Relay of Tyrosine Hydroxylase Neurons in the PVN. Cell Metabolism. 17(2). 236–248. 213 indexed citations
15.
Baldock, Paul A., Frank Drießler, Shu Lin, et al.. (2012). The endogenous opioid dynorphin is required for normal bone homeostasis in mice. Neuropeptides. 46(6). 383–394. 15 indexed citations
16.
Lin, Shu, Lesley Castillo, Ronaldo F. Enriquez, et al.. (2011). Peripheral‐Specific Y2 Receptor Knockdown Protects Mice From High‐Fat Diet‐Induced Obesity. Obesity. 19(11). 2137–2148. 51 indexed citations
17.
Shi, Yan‐Chuan, Shu Lin, Iris P.L. Wong, et al.. (2010). NPY Neuron-Specific Y2 Receptors Regulate Adipose Tissue and Trabecular Bone but Not Cortical Bone Homeostasis in Mice. PLoS ONE. 5(6). e11361–e11361. 81 indexed citations
18.
Castillo, Lesley, Marie-Christine Étienne-Grimaldi, Jean–Louis Fischel, et al.. (2004). Pharmacological background of EGFR targeting. Annals of Oncology. 15(7). 1007–1012. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vittoria Carnicelli Breakdown of academic impact, for papers by Fabin Dang Breakdown of academic impact, for papers by Jan Kroon Breakdown of academic impact, for papers by Katja Kaipio Breakdown of academic impact, for papers by Valérie Gratio Breakdown of academic impact, for papers by Connie Wang Breakdown of academic impact, for papers by Xueran Chen Breakdown of academic impact, for papers by Raymond Rothstein Breakdown of academic impact, for papers by Sandra Meulemans
Rankless by CCL
2026